Zylo Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2M

  • Investors
  • 14

Zylo Therapeutics General Information

Description

Developer of a topical delivery system designed to enhance drug delivery capabilities. The company's system uses engineered amorphous silica particles to encapsulate compounds and improve product performance by sustained release of medicine, enabling healthcare professionals to treat patients and consumers to achieve improved skincare and hair restoration.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 105A Ben Hamby Drive
  • Suite 105A
  • Greenville, SC 29615
  • United States
+1 (864)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Personal Products
Corporate Office
  • 105A Ben Hamby Drive
  • Suite 105A
  • Greenville, SC 29615
  • United States
+1 (864)

Zylo Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zylo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC 31-Mar-2025 $2M Completed Generating Revenue
15. Accelerator/Incubator 03-Oct-2023 Completed Generating Revenue
14. Accelerator/Incubator Completed Generating Revenue
13. Grant 31-May-2023 Completed Generating Revenue
12. Grant 16-Sep-2022 Completed Generating Revenue
11. Grant 19-Aug-2022 Completed Generating Revenue
10. Later Stage VC (Series B) 03-Jun-2022 Completed Generating Revenue
9. Early Stage VC 17-Nov-2021 Completed Generating Revenue
8. Grant 19-Jul-2021 $1.01M $12M Completed Generating Revenue
7. Grant 19-Jul-2021 $1.7M $12M Completed Generating Revenue
To view Zylo Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Zylo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a topical delivery system designed to enhance drug delivery capabilities. The company's system uses enginee
Drug Delivery
Greenville, SC
8 As of 2025

San Diego, CA
 

Sandy, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zylo Therapeutics Competitors (3)

One of Zylo Therapeutics’s 3 competitors is Dermata Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dermata Therapeutics Formerly VC-backed San Diego, CA
NoWonder Venture Capital-Backed Sandy, UT
Sol-Gel Technologies Formerly PE-Backed Ness Ziona, Israel
You’re viewing 3 of 3 competitors. Get the full list »

Zylo Therapeutics Patents

Zylo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025064867-A1 Delivery system for mitochondrial health enhancers Inactive 21-Sep-2023
WO-2021080968-A1 Delivery systems and method using cannabinoids for treatment of inflammatory disorders Inactive 22-Oct-2019
AU-2020296106-A1 Sulfur functionalized monoliths and particles derived from the same as nitric oxide carriers for pharmaceutical and cosmetic applications Active 19-Jun-2019
AU-2020296106-B2 Sulfur functionalized monoliths and particles derived from the same as nitric oxide carriers for pharmaceutical and cosmetic applications Active 19-Jun-2019
CA-3164746-A1 Sulfur functionalized monoliths and particles derived from the same as nitric oxide carriers for pharmaceutical and cosmetic applications Active 19-Jun-2019 A61K9/501
To view Zylo Therapeutics’s complete patent history, request access »

Zylo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zylo Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endless Frontier Labs Accelerator/Incubator
National Institutes of Arthritis and Musculoskeletal Diseases Not-For-Profit Venture Capital
National Institute Of Allergy and Infectious Diseases Government
Arcview Ventures Corporate Venture Capital Minority
NIH Seed Not-For-Profit Venture Capital
You’re viewing 5 of 14 investors. Get the full list »

Zylo Therapeutics Investments (1)

Zylo Therapeutics’s most recent deal was a Joint Venture with Joint Venture (Silo Pharma / Zylo Therapeutics). The deal was made on 11-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Silo Pharma / Zylo Therapeutics) 11-Aug-2021 Joint Venture Drug Discovery
To view Zylo Therapeutics’s complete investments history, request access »

Zylo Therapeutics FAQs

  • When was Zylo Therapeutics founded?

    Zylo Therapeutics was founded in 2017.

  • Where is Zylo Therapeutics headquartered?

    Zylo Therapeutics is headquartered in Greenville, SC.

  • What is the size of Zylo Therapeutics?

    Zylo Therapeutics has 8 total employees.

  • What industry is Zylo Therapeutics in?

    Zylo Therapeutics’s primary industry is Drug Delivery.

  • Is Zylo Therapeutics a private or public company?

    Zylo Therapeutics is a Private company.

  • What is Zylo Therapeutics’s current revenue?

    The current revenue for Zylo Therapeutics is .

  • How much funding has Zylo Therapeutics raised over time?

    Zylo Therapeutics has raised $20.1M.

  • Who are Zylo Therapeutics’s investors?

    Endless Frontier Labs, National Institutes of Arthritis and Musculoskeletal Diseases, National Institute Of Allergy and Infectious Diseases, Arcview Ventures, and NIH Seed are 5 of 14 investors who have invested in Zylo Therapeutics.

  • Who are Zylo Therapeutics’s competitors?

    Dermata Therapeutics, NoWonder, and Sol-Gel Technologies are competitors of Zylo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process